Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

Sallee FR.

Postgrad Med. 2010 Sep;122(5):78-87. doi: 10.3810/pgm.2010.09.2204. Review.

PMID:
20861591
2.

Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Childress AC.

Adv Ther. 2012 May;29(5):385-400. doi: 10.1007/s12325-012-0020-1. Epub 2012 May 18. Review.

PMID:
22610723
3.

Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.

Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA.

Clin Ther. 2013 Nov;35(11):1778-93. doi: 10.1016/j.clinthera.2013.09.005. Epub 2013 Oct 16. Review.

PMID:
24139092
4.

A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.

Sallee F, Connor DF, Newcorn JH.

J Child Adolesc Psychopharmacol. 2013 Jun;23(5):308-19. doi: 10.1089/cap.2013.0028. Review.

PMID:
23782125
5.

Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychiatry. 2006;67 Suppl 8:32-8. Review.

PMID:
16961428
6.

Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Pliszka SR.

CNS Spectr. 2003 Apr;8(4):253-8. Review.

PMID:
12679740
7.

Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.

Childress AC, Sallee FR.

Drugs Today (Barc). 2012 Mar;48(3):207-17. doi: 10.1358/dot.2012.48.3.1750904. Review.

PMID:
22462040
8.

Psychopharmacology of ADHD in adolescents.

Greydanus DE, Sloane MA, Rappley MD.

Adolesc Med. 2002 Oct;13(3):599-624. Review.

PMID:
12270803
9.

Pharmacological management of attention-deficit hyperactivity disorder.

Reeves G, Schweitzer J.

Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. Review.

PMID:
15163276
10.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
11.

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.

Chan E, Fogler JM, Hammerness PG.

JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453. Review.

PMID:
27163988
12.

Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.

Scahill L, Barloon L, Farkas L.

J Child Adolesc Psychiatr Nurs. 1999 Oct-Dec;12(4):168-73. Review. No abstract available.

PMID:
10876518
13.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
14.

Innovations and recent trends in the treatment of ADHD.

Madaan V, Kinnan S, Daughton J, Kratochvil CJ.

Expert Rev Neurother. 2006 Sep;6(9):1375-85. Review.

PMID:
17009924
15.

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).

Sallee FR, Eaton K.

Expert Opin Pharmacother. 2010 Oct;11(15):2549-56. doi: 10.1517/14656566.2010.517523. Review.

PMID:
20831361
16.

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.

Arnsten AF, Scahill L, Findling RL.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):393-406. Review.

PMID:
17822336
17.

The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.

Himpel S, Banaschewski T, Heise CA, Rothenberger A.

Expert Opin Drug Saf. 2005 Mar;4(2):311-21. Review.

PMID:
15794722
18.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

19.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
20.

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.

Slatkoff J, Greenfield B.

Expert Opin Investig Drugs. 2006 Jun;15(6):649-67. Review.

PMID:
16732717

Supplemental Content

Support Center